KWC/H Knowlton Capital

LGC Capital Announces Closing of Investment in Italian Cannabis Producer, Evolution

LGC Capital Announces Closing of Investment in Italian Cannabis Producer, Evolution

MONTREAL, May 29, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSXV: LG) (OTCQB: LGGCF) ("LGC" or the “Corporation”) announces it has closed its previously announced transaction with 9379-1432 Québec Inc., the Canadian incorporated parent company of Evolution BNK and Evolution ATM (collectively referred to as “Evolution”).

On 13 August 2018, LGC and Evolution entered into a convertible debenture indenture agreement (the “Loan”) for Euro 3 million. The Loan, the proceeds of which have been paid over to Evolution, is convertible into a 49% equity interest in Evolution and bears interest at the rate of 10%. 

Evolution is a legal cannabis (less than 0.2% THC) cultivation facility based in Pavia, Italy. Evolution is completing the retrofit of its 22,000 sq. ft. indoor facility within their 70,000 sq. ft. compound in Pavia, Italy for the production of high CBD, low (<0.2%) THC cannabis. Tests have been consistently positive as the product is well within the legal THC content set by the Italian Ministry of Health.  Estimated margins will be greater than 50% due to its patented energy usage technology and is well placed for any margin compression expected in Europe. 

Mazen Haddad, CEO LGC Capital “The value driver for Evolution is its low cost cultivation capacity which may offer synergistic benefits for other LGC investee companies like Viridi and announced investee, EasyJoint who will require high quality, compliant product to meet the estimated demands from the European cannabis light and CBD markets.”

About LGC Capital Ltd ()

LGC Capital is a leading cannabis investment firm with a focus on the legal global cannabis market. Through its growing portfolio of investment companies, LGC is building a transversal integrated organization of interconnected legal cannabis companies with cultivation, processing and distribution in Australia, Jamaica, Switzerland, Italy, and Canada serving domestic and export markets. LGC Capital Ltd. is a Canadian incorporated public company listed on the TSX Venture Exchange (TSXV: LG) and the US OTC-QB exchange (OTCQB: LGGCF).

Through its partners and assuming pending transactions under review by the TSXV are approved, LGC presently will have interests in Jamaica, Switzerland, Italy, Canada and Australia.

LGC partners currently sell cannabis or cannabis-derived products across Switzerland and Italy under the ONE Premium Cannabis and EasyJoint brands as well as medical cannabis oils in Australia under the Little Green Pharma brand and Hemp-seeds based Medical devices class IIa and Nutritional supplements under Freia Farmaceutici Brands. LGC’s partners’ branded products are available in a variety of formats including medicines, Cosmetics, dry cannabis flower, tinctures, oils and seeds.

For further information please contact:

President, John McMullen, ,

Chief Financial Officer, Mark Shinners,

Caution Regarding Press Releases

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice Regarding Forward Looking Statements

This press release may contain forward-looking statements with respect to LGC and their respective operations, strategy, investments, financial performance and condition. These statements can generally be identified by use of forward-looking words such as “may”, “will”, “expect”, “estimate”, “anticipate”, “intends”, “believe” or “continue” or the negative thereof or similar variations. The actual results and performance of LGC and Evolution Bnk could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under “Risk Factors and Risk Management” in LGC’s Management’s Discussion and Analysis for the three months ended December 31, 2018, as filed on SEDAR (). The cautionary statements qualify all forward-looking statements attributable to LGC and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release and neither LGC nor Freia has any obligation to update such statements, except to the extent required by applicable securities laws.  Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

EN
29/05/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Knowlton Capital

 PRESS RELEASE

LGC Capital Ltd. Announces Name Change to Elixxer Ltd.

LGC Capital Ltd. Announces Name Change to Elixxer Ltd. MONTRÉAL, July 30, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSX-V: LG / OTCQB: LGGCF) is pleased to announce that the TSX Venture Exchange (the “TSX-V”) has conditionally approved the change of name of the Corporation to Elixxer Ltd.  The name change was approved by the Corporation’s shareholders at the annual and special meeting held on May 22, 2019 (see press release dated May 23, 2019). The Corporation expects the name change to become effective at the opening of markets on Tuesday, August 6, 2019.  The Corporation will trade und...

 PRESS RELEASE

EU GMP Facility for EVOLUTION BNK Moves to Next Stage of Approval

EU GMP Facility for EVOLUTION BNK Moves to Next Stage of Approval MONTREAL, July 24, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSXV: LG and OTC-QB: LGGCF) (“LGC”) LGC is pleased to announce that Evolution BNK’s Italian certifying consultants Studio Sannino S.a.s  have advised that Evolution BNK has now received its ISO 9001:2015 Certification for Production, processing, marketing of products derived from Industrial hemp for its Pavia facility in Italy. The following certification processes are now proceeding and under review from the relevant authorities: Agricultural sector certificat...

 PRESS RELEASE

EU Licensed European Pharmaceutical Company, Freia Farmaceutici Srl NE...

EU Licensed European Pharmaceutical Company, Freia Farmaceutici Srl NEWSFLASH MONTRÉAL, July 22, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSXV: LG and OTC-QB: LGGCF) (“LGC”) is pleased to announce that it has paid the 2nd Tranche, as contractually agreed, in acquiring an equity interest in the Italian pharmaceutical company, Freia Farmaceutici Srl (“Freia”). Freia () was founded in 2009 and is presently the only company in Italy and one of few in Europe, to have created and are marketing hemp based pharmaceutical products approved by the Italian Ministry of Health and licensed fo...

 PRESS RELEASE

LGC Capital Ltd. Announces Change in Financial Year-End

LGC Capital Ltd. Announces Change in Financial Year-End MONTRÉAL, July 16, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSX-V: LG / OTCQB: LGGCF) wishes to announce that it is changing its financial year-end to December 31 from its current year-end of September 30.  As a result, LGC will file an additional interim report as at September 30, 2019 and will report audited financial results for a 15-month transition year from October 1, 2018 to December 31, 2019 (with a comparative of the 12 months ended September 30, 2018). Afterwards, LGC will revert to a customary reporting calendar based on...

 PRESS RELEASE

LGC Capital, Ltd., announces Trichomed received its cultivation licens...

LGC Capital, Ltd., announces Trichomed received its cultivation license from Health Canada for its new cannabis facility in Brownsburg, Quebec MONTREAL, July 15, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSX-V: LG / OTCQB: LGGCF)   LGC Capital Ltd. (“LGC” or the “Company”), announces that Health Canada, on July 12th, awarded  Trichomed Corporation (Trichomed), its long awaited license to cultivate cannabis seeds and plants at its newly constructed facility in Brownsburg, Quebec.  As per the terms of its agreement with Trichomed, LGC is, now entitled to convert the first ranking secured...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch